netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Radium-223 dichloride found 3 matches

Open monograph to display formulary status BNF Category
  Radium-223 dichloride
(Xofigo®)
Malignant disease and immunosuppression - Prostate cancer and gonadorelin analogues - 08.03.04.02
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update (December 2017): Radium-223 dichloride (Xofigo▼): do not use in combination with abiraterone and prednisone/prednisolone, following clinical trial signal of increased risk of death and fractures   (08.03.04.02)
link in drug section NICE TA412: Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases (08.03.04.02)


 

netFormulary